A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip
Phase 2
- Conditions
- Hemophilia A With Inhibitor
- Interventions
- Drug: PEGylated Liposome (PEGLip)
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- Ascension Healthcare Development Limited
- Target Recruit Count
- 20
- Registration Number
- NCT04592692
- Locations
- 🇷🇺
Kemerovo District Clinical Hospital, Kemerovo, Russian Federation
🇷🇺Samara State Medical University, Samara, Russian Federation
🇷🇺Novosibirsk State Medical University, Novosibirsk City Haematology Center, Novosibirsk, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath